Sanofi Pasteur, the vaccines division of Sanofi, announced today that its first doses of Fluzone (flu vaccine) for the 2015-2016 influenza season have been released by the US FDA for shipment.

This represents the first of more than 65 million total doses of seasonal influenza vaccine that will be delivered to US healthcare providers and pharmacies beginning in July and continuing throughout the 2015-2016 flu season.

Sanofi Pasteur will supply a wide portfolio of Fluzone influenza vaccine options this season to meet the immunization needs of multiple age groups, from children as young as six months of age through adults 65 years of age and older:

  • Fluzone High-Dose vaccine
  • Fluzone Intradermal Quadrivalent vaccine
  • Fluzone Quadrivalent vaccine
  • Fluzone vaccine